Intarcia Therapeutics, Inc.

Intarcia Therapeutics, Inc.

Intarcia Therapeutics, Inc.

Intarcia Therapeutics is a biopharmaceutical company developing therapies fordiseases that require long-term chronic treatment.
Founded
1997
Raised
$1.2B
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$206,000,000
Venture capital - 2016
Bill & Melinda Gates Foundation
$215,000,000
Private equity - 2016
Team Size
50+
Employees
$206,000,000 Venture capital
MassDevice , FinSMEs , bizjournals

Gates Foundation puts $140m into $206m round for Intarcia

$215,000,000 Private equity
Fortune

Diabetes ‘Unicorn’ Raises Final VC Round Before IPO

FinSMEs

Intarcia Therapeutics Closes $215M First Close of Equity Financing

Funding Health
$75,000,000 Debt financing
MassDevice

Intarcia raises another $75m, touts top-line safety data in pivotal trial